October 13, 2024

Bionpa

You are Your Only Limit

Should You Hold Cara Therapeutics Inc (CARA) in Biotechnology Industry?

Should You Hold Cara Therapeutics Inc (CARA) in Biotechnology Industry?
News Home

Friday, March 17, 2023 03:23 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Cara Therapeutics Inc (CARA) in Biotechnology Industry?

The 37 rating InvestorsObserver gives to Cara Therapeutics Inc (CARA) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 31 percent of stocks in the Biotechnology industry, CARA’s 37 overall rating means the stock scores better than 37 percent of all stocks.

Overall Score - 37
CARA has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on CARA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 37 means the stock is more attractive than 37 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What’s Happening With Cara Therapeutics Inc Stock Today?

Cara Therapeutics Inc (CARA) stock is trading at $5.40 as of 3:15 PM on Friday, Mar 17, a drop of -$0.38, or -6.57% from the previous closing price of $5.78. The stock has traded between $5.38 and $5.76 so far today. Volume today is low. So far 497,681 shares have traded compared to average volume of 774,107 shares.

Click Here to get the full Stock Report for Cara Therapeutics Inc stock.

You May Also Like

bionpa.com All rights reserved. | Newsphere by AF themes.